Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices

Bissessor, Naylin; Wong, Allison W.; Hourigan, Lisa; Jayasinghe, Rohan; Scalia, G.; Burstow, Darryl J.; Griffiths, Lyn R.; Savage, M.; Walters, D.

doi:10.1016/j.carrev.2010.06.001

Cited by 16 publications

(6 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As recently reported by single centre [26, 27], as well as by a multicenter Italian study [28], we also observed that percutaneous PFO closure may be superior to medical treatment in preventing stroke recurrence. However, there is evidence suggesting that this approach may be less effective in older patients [29].…”

Section: Discussionsupporting

confidence: 86%

Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale

et al. 2011

View full text Add to dashboard Cite

Purpose. We investigated stroke recurrence in patients with acute ischemic stroke of undetermined aetiology, with or without a patent foramen ovale (PFO). Methods. Consecutive stroke patients underwent to Transcranial Doppler and Transesophageal Echocardiography for PFO detection. Secondary stroke prevention was based on current guidelines. Results. PFO was detected in 57/129 (44%) patients. The rate of recurrent stroke did not significantly differ between patients with and without a PFO: 0.0% versus 1.4% (1 week), 1.7% versus 2.7% (1 month), and 3.5% versus 4.2% (3 months), respectively. The 2-year rates were 10.4% (5/48) in medically treated PFO and 8.3% (6/72) in PFO-negative patients (P = 0.65), with a relative risk of 1.25. No recurrent events occurred in 9 patients treated with percutaneous closure of PFO. Conclusion. PFO was not associated with increased rate of recurrent stroke. Age-related factors associated with stroke recurrence in cryptogenic stroke should be taken into account when patients older than 55 years are included in PFO studies.

show abstract

Section: Discussionsupporting

confidence: 86%

Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale

et al. 2011

View full text Add to dashboard Cite

show abstract

“…PFO can be closed percutaneously with a low rate of significant residual shunting and very few complications. After closure of the PFO, no patient experienced a recurrent paradoxical embolic event during the medium-term (up to four years) follow-up period [9] .…”

Section: Discussionmentioning

confidence: 95%

“…Although ischemic events can occur in most organs, including the brain, eyes, kidneys, spleen, and intestines, and in the upper and lower extremities, stroke is the most usual common manifestation of paradoxical embolism. The prevalence of PFO is estimated to be 45% among patients with cryptogenic stroke or transient ischemic attacks [9] . In a recent study the most common reason for the primary referral of patients with PFO-related conditions for PFO closure ( n =416) was cryptogenic stroke ( n =219).…”

Section: Discussionmentioning

confidence: 99%

Renal infarction caused by paradoxical embolism through a patent foramen ovale

Jeong

Lee

Joung

et al. 2012

Kidney Research and Clinical Practice

View full text Add to dashboard Cite

A 48-year-old man presented with acute right flank pain. A computed tomography scan revealed right renal infarction. Because he had no thrombosis in the renal vessels and no clear embolic source, a further examination was performed to find the cause of the renal infarction. On transesophageal echocardiography, a right-to-left shunt during the Valsalva maneuver established a diagnosis of patent foramen ovale. This is a case of paradoxical embolism through a PFO leading to renal infarction.

show abstract

“…It is also important to distinguish PFO and IPS on echocardiography. Although, they may present with similar clinical presentations of hypoxia, therapy may differ, particularly with the advent of closure devices for PFO . TTE with saline contrast does not consistently allow for direct visualization of bubbles traversing the atrial septum in the case of a PFO.…”

mentioning

confidence: 99%

“…Although, they may present with similar clinical presentations of hypoxia, therapy may differ, particularly with the advent of closure devices for PFO. 17 TTE with saline contrast does not consistently allow for direct visualization of bubbles traversing the atrial septum in the case of a PFO. In addition, TTE only allows for limited visualization of superior and inferior pulmonic veins.…”

mentioning

confidence: 99%

Determination of the Optimum Number of Cardiac Cycles to Differentiate Intra‐Pulmonary Shunt and Patent Foramen Ovale by Saline Contrast Two‐ and Three‐Dimensional Echocardiography

et al. 2013

View full text Add to dashboard Cite

show abstract

Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices

Cited by 16 publications

References 18 publications

Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale

Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale

Renal infarction caused by paradoxical embolism through a patent foramen ovale

Determination of the Optimum Number of Cardiac Cycles to Differentiate Intra‐Pulmonary Shunt and Patent Foramen Ovale by Saline Contrast Two‐ and Three‐Dimensional Echocardiography

Contact Info

Product

Resources

About